Ownership history in CITIGROUP INC · 30 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in ORAMED PHARM INC COM NEW (ORMP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 4 | -41,467 | -100.0% | 0.00% | $11 | $2.46 |
| 2023 Q3 | ADDED | 41,471 | +4,027 | +10.8% | 0.00% | $108K | $2.43 |
| 2023 Q2 | ADDED | 37,444 | +12,388 | +49.4% | 0.00% | $134K | $3.34 |
| 2023 Q1 | REDUCED | 25,056 | -40,834 | -62.0% | 0.00% | $55K | $2.03 |
As of 2025 Q4 — sorted by position size